HIKMA Pharmaceuticals PLC — Director's Dealing 2020

Mar 24, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3696H

Hikma Pharmaceuticals Plc

24 March 2020

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Cynthia Schwalm

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

Market purchase of 1,100 Ordinary Shares by Cynthia Schwalm

c)

Price(s) and volume(s)

Price(s): £18.19

Volume(s): 1,100

d)

Aggregated information

-       Volume

-       Price

1,100

£20,009

e)

Date of the transaction

20 March 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

24 March 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBGGDXBUDDGGS